Amendment: SEC Form SC 13G/A filed by Applied Therapeutics Inc.

11/14/24 5:47:55 PM ET

$APLT

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $APLT alert in real time by email

SC 13G/A 1 tm2428137d7_sc13ga.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Applied Therapeutics, Inc.

(Name of Issuer)

Common Stock $0.0001 par value per share

(Title of Class of Securities)

03828A101

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨	Rule 13d-1(b)
x	Rule 13d-1(c)
¨	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 03828A101

Page 2 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners III, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

(2)

Consists of (i) 1,161,543 shares and 502,131 shares issuable upon the exercise of immediately exercisable warrants (“Warrants”) held by Venrock Healthcare Capital Partners III, L.P.; (ii) 116,170 shares and 50,233 shares issuable upon the exercise of Warrants held by VHCP Co-Investment Holdings III, LLC; and (iii) 8,547,287 shares and 1,278,701 shares issuable upon the exercise of Warrants held by Venrock Healthcare Capital Partners EG, L.P. The share numbers in the preceding sentence represent the maximum number of shares of common stock issuable upon exercise of the Warrants held by the Reporting Persons as a result of the beneficial ownership provision described in the following sentence. Under the terms of the Warrants, the Issuer may not effect the exercise of any such Warrant, and a holder will not be entitled to exercise any portion of such Warrant, if, upon giving effect to such exercise, the aggregate number of shares of common stock beneficially owned by the holder (together with its affiliates and other attribution parties) would exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise.

(3)

This percentage is calculated based upon the sum of (i) 114,846,271 shares of the Issuer’s Common Stock outstanding as of August 6, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2024; and (ii) 1,831,065 shares issuable upon the exercise of the Warrants described in Footnote 2 above.

CUSIP No. 03828A101

Page 3 of 14

1.	Names of Reporting Persons VHCP Co-Investment Holdings III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

Consists of (i) 1,161,543 shares and 502,131 shares issuable upon the exercise of immediately exercisable Warrants held by Venrock Healthcare Capital Partners III, L.P.; (ii) 116,170 shares and 50,233 shares issuable upon the exercise of Warrants held by VHCP Co-Investment Holdings III, LLC; and (iii) 8,547,287 shares and 1,278,701 shares issuable upon the exercise of Warrants held by Venrock Healthcare Capital Partners EG, L.P. The share numbers in the preceding sentence represent the maximum number of shares of common stock issuable upon exercise of the Warrants held by the Reporting Persons as a result of the beneficial ownership provision described in the following sentence. Under the terms of the Warrants, the Issuer may not effect the exercise of any such Warrant, and a holder will not be entitled to exercise any portion of such Warrant, if, upon giving effect to such exercise, the aggregate number of shares of common stock beneficially owned by the holder (together with its affiliates and other attribution parties) would exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise.

(3)

CUSIP No. 03828A101

Page 4 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners EG, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

(2)

(3)

CUSIP No. 03828A101

Page 5 of 14

1.	Names of Reporting Persons VHCP Management III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 03828A101

Page 6 of 14

1.	Names of Reporting Persons VHCP Management EG, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 03828A101

Page 7 of 14

1.	Names of Reporting Persons Shah, Nimish
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 03828A101

Page 8 of 14

1.	Names of Reporting Persons Koh, Bong
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

11,656,065 (2)

Sole Dispositive Power

Shared Dispositive Power

11,656,065 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 11,656,065 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 9.99% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 03828A101

Page 9 of 14

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP EG”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP III LP, VHCP Co-Investment III, VHCP EG and VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of the Common Stock of Applied Therapeutics, Inc.

Item 1.
	(a)	Name of Issuer Applied Therapeutics, Inc.

	(b)	Address of Issuer’s Principal Executive Offices 545 Fifth Avenue, Suite 1400 New York, NY 10017

Item 2.
	(a)	Name of Person Filing Venrock Healthcare Capital Partners III, L.P. VHCP Co-Investment Holdings III, LLC Venrock Healthcare Capital Partners EG, L.P. VHCP Management III, LLC VHCP Management EG, LLC Nimish Shah Bong Koh

(b)	Address of Principal Business Office or, if none, Residence

	New York Office:	Palo Alto Office:

	7 Bryant Park	3340 Hillview Avenue
	23rd Floor	Palo Alto, CA 94304
	New York, NY 10018

	(c)	Citizenship All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

	(d)	Title of Class of Securities Common Stock $0.0001 par value

	(e)	CUSIP Number 03828A101

CUSIP No. 03828A101

Page 10 of 14

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	Not applicable

Item 4.	Ownership
	(a)	Amount beneficially owned as of September 30, 2024:

Venrock Healthcare Capital Partners III, L.P.	11,656,065	(1)
VHCP Co-Investment Holdings III, LLC	11,656,065	(1)
Venrock Healthcare Capital Partners EG, L.P.	11,656,065	(1)
VHCP Management III, LLC	11,656,065	(1)
VHCP Management EG, LLC	11,656,065	(1)
Nimish Shah	11,656,065	(1)
Bong Koh	11,656,065	(1)

(b)

Percent of class as of September 30, 2024:

Venrock Healthcare Capital Partners III, L.P.	9.99	%(2)
VHCP Co-Investment Holdings III, LLC	9.99	%(2)
Venrock Healthcare Capital Partners EG, L.P.	9.99	%(2)
VHCP Management III, LLC	9.99	%(2)
VHCP Management EG, LLC	9.99	%(2)
Nimish Shah	9.99	%(2)
Bong Koh	9.99	%(2)


	(c)	Number of shares as to which the person has, as of September 30, 2024:

(i)

Sole power to vote or to direct the vote:

	Venrock Healthcare Capital Partners III, L.P.			0
	VHCP Co-Investment Holdings III, LLC			0
	Venrock Healthcare Capital Partners EG, L.P.			0
	VHCP Management III, LLC			0
	VHCP Management EG, LLC			0
	Nimish Shah			0
	Bong Koh			0


	(ii)	Shared power to vote or to direct the vote:

	Venrock Healthcare Capital Partners III, L.P.				11,656,065(1)
	VHCP Co-Investment Holdings III, LLC				11,656,065(1)
	Venrock Healthcare Capital Partners EG, L.P.				11,656,065(1)
	VHCP Management III, LLC				11,656,065(1)
	VHCP Management EG, LLC				11,656,065(1)
	Nimish Shah				11,656,065(1)
	Bong Koh				11,656,065(1)

CUSIP No. 03828A101

Page 11 of 14

(iii)

Sole power to dispose or to direct the disposition of:

	Venrock Healthcare Capital Partners III, L.P.				0
	VHCP Co-Investment Holdings III, LLC				0
	Venrock Healthcare Capital Partners EG, L.P.				0
	VHCP Management III, LLC				0
	VHCP Management EG, LLC				0
	Nimish Shah				0
	Bong Koh				0

(iv)

Shared power to dispose or to direct the disposition of:

	Venrock Healthcare Capital Partners III, L.P.				11,656,065(1)
	VHCP Co-Investment Holdings III, LLC				11,656,065(1)
	Venrock Healthcare Capital Partners EG, L.P.				11,656,065(1)
	VHCP Management III, LLC				11,656,065(1)
	VHCP Management EG, LLC				11,656,065(1)
	Nimish Shah				11,656,065(1)
	Bong Koh				11,656,065(1)

(1)     Consists of (i) 1,161,543 shares and 502,131 shares issuable upon the exercise of immediately exercisable Warrants held by Venrock Healthcare Capital Partners III, L.P.; (ii) 116,170 shares and 50,233 shares issuable upon the exercise of Warrants held by VHCP Co-Investment Holdings III, LLC; and (iii) 8,547,287 shares and 1,278,701 shares issuable upon the exercise of Warrants held by Venrock Healthcare Capital Partners EG, L.P. The share numbers in the preceding sentence represent the maximum number of shares of common stock issuable upon exercise of the Warrants held by the Reporting Persons as a result of the beneficial ownership provision described in the following sentence. Under the terms of the Warrants, the Issuer may not effect the exercise of any such Warrant, and a holder will not be entitled to exercise any portion of such Warrant, if, upon giving effect to such exercise, the aggregate number of shares of common stock beneficially owned by the holder (together with its affiliates and other attribution parties) would exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise.

VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. VHCP Management EG, LLC is the general partner of Venrock Healthcare Capital Partners EG, L.P. Messrs. Shah and Koh are the voting members of VHCP Management III, LLC and VHCP Management EG, LLC.

(2)     This percentage is calculated based upon the sum of (i) 114,846,271 shares of the Issuer’s Common Stock outstanding as of August 6, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2024; and (ii) 1,831,065 shares issuable upon the exercise of the Warrants described in Footnote 1 above.

CUSIP No. 03828A101

Page 12 of 14

Item 5.	Ownership of Five Percent or Less of a Class
	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨

Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
	Not applicable

Item 8.	Identification and Classification of Members of the Group
	Not applicable

Item 9.	Notice of Dissolution of Group
	Not applicable

Item 10.	Certification
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

CUSIP No. 03828A101

Page 13 of 14

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 14, 2024

Venrock Healthcare Capital Partners III, L.P.		Venrock Healthcare Capital Partners EG, L.P.

By:	VHCP Management III, LLC	By:	VHCP Management EG, LLC
Its:	General Partner	Its:	General Partner

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

VHCP Co-Investment Holdings III, LLC

By:	VHCP Management III, LLC
Its:	Manager

By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther
	Its: Authorized Signatory

VHCP Management III, LLC		VHCP Management EG, LLC

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

Nimish Shah

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

Bong Koh

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

CUSIP No. 03828A101

Page 14 of 14

EXHIBITS

Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on May 8, 2023)

Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed May 8, 2023)

Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on May 8, 2023)

Get the next $APLT alert in real time by email

Date	Price Target	Rating	Analyst
12/23/2024		Outperform → Mkt Perform	William Blair
12/2/2024	$13.00 → $2.00	Buy → Neutral	UBS
11/29/2024	$12.00 → $4.00	Outperform → Sector Perform	RBC Capital Mkts
7/31/2024		Outperform	William Blair
3/26/2024	$12.00	Outperform	RBC Capital Mkts
2/22/2024	$12.00	Outperform	Leerink Partners
1/4/2022	$44.00 → $7.00	Overweight → Equal-Weight	Barclays
8/27/2021	$10.00	Neutral → Sell	Goldman Sachs

Amendment: SEC Form SC 13G/A filed by Applied Therapeutics Inc.

Chat with this insight

Recent Analyst Ratings for
$APLT

$APLT
Press Releases

Fastest customizable press release news feed in the world

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

$APLT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Applied Therapeutics downgraded by William Blair

Applied Therapeutics downgraded by UBS with a new price target

Applied Therapeutics downgraded by RBC Capital Mkts with a new price target

$APLT
Large Ownership Changes

This live feed shows all institutional transactions in real time.